194 related articles for article (PubMed ID: 28520215)
1. Aspirin and the risk of cardiovascular events in atherosclerosis patients with and without prior ischemic events.
Bavry AA; Elgendy IY; Elbez Y; Mahmoud AN; Sorbets E; Steg PG; Bhatt DL;
Clin Cardiol; 2017 Sep; 40(9):732-739. PubMed ID: 28520215
[TBL] [Abstract][Full Text] [Related]
2. Impact of aspirin according to type of stable coronary artery disease: insights from a large international cohort.
Bavry AA; Gong Y; Handberg EM; Cooper-DeHoff RM; Pepine CJ
Am J Med; 2015 Feb; 128(2):137-43. PubMed ID: 25447610
[TBL] [Abstract][Full Text] [Related]
3. Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events.
Lemesle G; Ducrocq G; Elbez Y; Van Belle E; Goto S; Cannon CP; Bauters C; Bhatt DL; Steg PG;
Clin Cardiol; 2017 Oct; 40(10):932-939. PubMed ID: 28692742
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Triflusal with Aspirin in the Secondary Prevention of Atherothrombotic Events; Α Randomised Clinical Trial.
Kalantzi KI; Ntalas IV; Chantzichristos VG; Tsoumani ME; Adamopoulos D; Asimakopoulos C; Bourdakis A; Darmanis P; Dimitriadou A; Gkiokas S; Ipeirotis K; Kitikidou K; Klonaris I; Kostaki A; Logothetis D; Mainas K; Mais T; Maragiannis A; Martiadou K; Mavronasos K; Michelongonas I; Mitropoulos D; Papadimitriou G; Papadopoulos A; Papaioakeim M; Sofillas K; Stabola S; Stefanakis E; Stergiou D; Thoma M; Zenetos A; Zisekas S; Goudevenos JA; Panagiotakos DB; Tselepis AD
Curr Vasc Pharmacol; 2019; 17(6):635-643. PubMed ID: 29866011
[TBL] [Abstract][Full Text] [Related]
5. Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54).
Bonaca MP; Goto S; Bhatt DL; Steg PG; Storey RF; Cohen M; Goodrich E; Mauri L; Ophuis TO; Ruda M; Špinar J; Seung KB; Hu D; Dalby AJ; Jensen E; Held P; Morrow DA; Braunwald E; Sabatine MS
Circulation; 2016 Sep; 134(12):861-71. PubMed ID: 27576775
[TBL] [Abstract][Full Text] [Related]
6. Association of Diabetic Status and Glycemic Control With Ischemic and Bleeding Outcomes in Patients With Stable Coronary Artery Disease: The 5-Year CORONOR Registry.
Lemesle G; Meurice T; Tricot O; Lamblin N; Bauters C
J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728374
[TBL] [Abstract][Full Text] [Related]
7. Ticagrelor in Patients with Stable Coronary Disease and Diabetes.
Steg PG; Bhatt DL; Simon T; Fox K; Mehta SR; Harrington RA; Held C; Andersson M; Himmelmann A; Ridderstråle W; Leonsson-Zachrisson M; Liu Y; Opolski G; Zateyshchikov D; Ge J; Nicolau JC; Corbalán R; Cornel JH; Widimský P; Leiter LA;
N Engl J Med; 2019 Oct; 381(14):1309-1320. PubMed ID: 31475798
[TBL] [Abstract][Full Text] [Related]
8. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.
Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510
[TBL] [Abstract][Full Text] [Related]
9. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
Bangalore S; Steg G; Deedwania P; Crowley K; Eagle KA; Goto S; Ohman EM; Cannon CP; Smith SC; Zeymer U; Hoffman EB; Messerli FH; Bhatt DL;
JAMA; 2012 Oct; 308(13):1340-9. PubMed ID: 23032550
[TBL] [Abstract][Full Text] [Related]
10. NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease.
Kohli P; Steg PG; Cannon CP; Smith SC; Eagle KA; Ohman EM; Alberts MJ; Hoffman E; Guo J; Simon T; Sorbets E; Goto S; Bhatt DL;
Am J Med; 2014 Jan; 127(1):53-60.e1. PubMed ID: 24280110
[TBL] [Abstract][Full Text] [Related]
11. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis.
Bhatt DL; Eagle KA; Ohman EM; Hirsch AT; Goto S; Mahoney EM; Wilson PW; Alberts MJ; D'Agostino R; Liau CS; Mas JL; Röther J; Smith SC; Salette G; Contant CF; Massaro JM; Steg PG;
JAMA; 2010 Sep; 304(12):1350-7. PubMed ID: 20805624
[TBL] [Abstract][Full Text] [Related]
12. Residual Ischemic Risk and Its Determinants in Patients With Previous Myocardial Infarction and Without Prior Stroke or TIA: Insights From the REACH Registry.
Abtan J; Bhatt DL; Elbez Y; Sorbets E; Eagle K; Ikeda Y; Wu D; Hanson ME; Hannachi H; Singhal PK; Steg PG; Ducrocq G;
Clin Cardiol; 2016 Nov; 39(11):670-677. PubMed ID: 27588731
[TBL] [Abstract][Full Text] [Related]
13. Aspirin Versus Clopidogrel for Type 2 Diabetic Patients with First-Ever Noncardioembolic Acute Ischemic Stroke: Ten-Year Survival Data from the Athens Stroke Outcome Project.
Milionis H; Ntaios G; Papavasileiou V; Spengos K; Manios E; Elisaf M; Vemmos K
J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2769-2777. PubMed ID: 28756905
[TBL] [Abstract][Full Text] [Related]
14. Asymptomatic individuals with a positive family history for premature coronary artery disease and elevated coronary calcium scores benefit from statin treatment: a post hoc analysis from the St. Francis Heart Study.
Mulders TA; Sivapalaratnam S; Stroes ES; Kastelein JJ; Guerci AD; Pinto-Sietsma SJ
JACC Cardiovasc Imaging; 2012 Mar; 5(3):252-60. PubMed ID: 22421169
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Evolution of Premature Coronary Artery Disease.
Collet JP; Zeitouni M; Procopi N; Hulot JS; Silvain J; Kerneis M; Thomas D; Lattuca B; Barthelemy O; Lavie-Badie Y; Esteve JB; Payot L; Brugier D; Lopes I; Diallo A; Vicaut E; Montalescot G;
J Am Coll Cardiol; 2019 Oct; 74(15):1868-1878. PubMed ID: 31601367
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
[TBL] [Abstract][Full Text] [Related]
17. Ischemic stroke in patients receiving aspirin.
Pujol Lereis VA; Ameriso S; Povedano GP; Ameriso SF
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):868-72. PubMed ID: 21703876
[TBL] [Abstract][Full Text] [Related]
18. PR interval prolongation in coronary patients or risk equivalent: excess risk of ischemic stroke and vascular pathophysiological insights.
Chan YH; Hai JJ; Lau KK; Li SW; Lau CP; Siu CW; Yiu KH; Tse HF
BMC Cardiovasc Disord; 2017 Aug; 17(1):233. PubMed ID: 28836952
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial.
Vanassche T; Verhamme P; Anand SS; Shestakovska O; Fox KA; Bhatt DL; Avezum A; Alings M; Aboyans V; Maggioni AP; Widimsky P; Berkowitz SD; Yusuf S; Connolly SJ; Eikelboom JW; Bosch J
Eur J Prev Cardiol; 2020 Feb; 27(3):296-307. PubMed ID: 31615291
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers for risk stratification in secondary cardiovascular prevention. A role of red blood cell distribution width and calcium score.
Oleksiak A; Kruk M; Lenarczyk E; Pawelec M; Rajska E; Wilkońska P; Dzielińska Z; Demkow M; Witkowski A; Pręgowski J; Kępka C; Rużyłło W
Atherosclerosis; 2016 Mar; 246():57-62. PubMed ID: 26756971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
